Intervention

Docetaxel, Cisplatin

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions3

Lead sponsors shown2

Clinical trials

2 shown

Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung CarcinomaNCT00617656 · 2008-02-01

Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC)NCT00173888 · 2003-07-01

Common conditions

BRCA1 Mutation1 Non Small Cell Lung Cancer1 Non-small Cell Lung Cancer1

Leading sponsors

National Taiwan University Hospital1 Spanish Lung Cancer Group1

Trial status mix

COMPLETED1

TERMINATED1

Phase mix

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.